Alistair A. Mathie
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Equivalent gain-of-function variants in KCNK3 and KCNK9 and their contribution to distinct TASK K2P channelopathies.
Journal: The Journal of general physiology
Published: February 27, 2026
Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806.
Journal: Pharmacology research & perspectives
Published: January 23, 2026
The Concise Guide to PHARMACOLOGY 2025/26: Transporters.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Enzymes.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Introduction and Other Protein Targets.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
TASK-3, two-pore potassium channels, contribute to circadian rhythms in the electrical properties of the suprachiasmatic nucleus and play a role in driving stable behavioural photic entrainment.
Journal: Chronobiology international
Published: May 17, 2024
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels.
Journal: British journal of pharmacology
Published: December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors.
Journal: British journal of pharmacology
Published: December 20, 2023
Last Updated: 09/26/2026